I-Tilmicosin Phosphate
.png)
.png)
.png)
.png)
I-Tilmicosin Phosphate
I-Tilmicosin liyeza lonyango lwezilwanyana, lisetyenziselwa uthintelo kunye nokunyanga inyumoniya yenkomo kunye ne-mastitis ebangelwa yintsholongwane ebuthathaka, kunye nesifo se-mycoplasma kwiihagu kunye neenkukhu.
I-Pharmacology
(1)Pharmacodynamics:Impembelelo ye-antibacterial ifana ne-tylosin, ngokukodwa ngokuchasene neebhaktheriya ze-Gram-positive, kwaye iphinda isebenze kwiibhaktheriya ezimbalwa ze-Gram-negative kunye ne-mycoplasma.Umsebenzi wayo ochasene ne-Actinobacillus pleuropneumoniae, i-Pasteurella kunye ne-Mycoplasma yemfuyo kunye neenkukhu zinamandla kune-tylosin.Kuye kwaxelwa ukuba i-95% yeentlobo ze-Pasteurella hemolytica zivakalelwa kule mveliso.
(2)I-Pharmacokinetics:Emva kokulawulwa komlomo okanye i-injection subcutaneous, le mveliso ine-absorption ekhawulezayo, ukungena kwezicubu ezinamandla kunye nomthamo omkhulu wokusabalalisa.
Ukulumkela
(1) Isitofu se-intravenous sale mveliso akuvumelekanga.Inaliti enye ye-5 mg/kg iyabulala iinkomo, kwaye iyingozi nakwiihagu, iiprimates kunye namahashe.
(2) Ukusabela kwendawo (i-edema, njl.) inokuthi yenzeke kwi-injection ye-intramuscular and subcutaneous, kwaye ayikwazi ukudibana namehlo.Indawo yokutofa engaphantsi kwesikhumba kufuneka ikhethwe kwindawo esemva kwegxalaba lenkomo kwimbambo.
3(4) Isimo se-cardiovascular kufuneka sibekwe esweni ngokusondeleyo xa usebenzisa le mveliso.
(5) Inaliti yale mveliso kufuneka isetyenziswe ngononophelo kwizilwanyana ngaphandle kweenkomo.
(6) Ngethuba lokurhoxisa, i-injection ye-subcutaneous yenziwa kwiintsuku ze-28, kwaye iihagu zilawulwa ngomlomo ngeentsuku ze-14.Iinkomo zobisi kunye namathole enyama ngexesha lokusenga akuvumelekanga.
Umxholo
≥ 98%
Inkcazo
USP/CVP
Ukupakisha
25kg/igubu lekhadibhodi
Amalungiselelo
10%, 20%, 37.5% Tilmicosin phosphate powder soluble;
I-Hebei Veyong Pharmaceutical Co., Ltd, yasekwa kwi-2002, ehlala kwisiXeko saseShijiazhuang, kwiPhondo laseHebei, eChina, ecaleni kwe-Capital Beijing.Ulishishini elikhulu leyeza lezilwanyana eliqinisekisiweyo le-GMP, eline-R&D, imveliso kunye nokuthengiswa kwee-APIs zonyango lwezilwanyana, amalungiselelo, ukutya okuxutywe kwangaphambili kunye nezongezo zokutya.NjengeZiko lobuGcisa lePhondo, iVeyong iye yaseka inkqubo yeR&D ehlaziyiweyo yeyeza elitsha lezilwanyana, kwaye lishishini elaziwa kuzwelonke leteknoloji esekelwe kunyango lwezilwanyana, kukho iingcali zobugcisa ezingama-65.I-Veyong ineziseko ezimbini zokuvelisa: i-Shijiazhuang kunye ne-Ordos, apho isiseko se-Shijiazhuang sihlanganisa indawo ye-78,706 m2, kunye neemveliso ze-API ze-13 ezibandakanya i-Ivermectin, i-Eprinomectin, i-Tiamulin Fumarate, i-Oxytetracycline hydrochloride ects, kunye ne-11, i-injection oral solutions, i-injection oral solutions. , i-premix, i-bolus, i-pesticides kunye ne-disinfectant, njl.IVeyong ibonelela ngee-APIs, ngaphezulu kwe-100 yamalungiselelo eleyibhile, kunye nenkonzo ye-OEM & ODM.
I-Veyong ibona ukubaluleka okukhulu kulawulo lwenkqubo ye-EHS(Environment, Health & Safety), kwaye ifumene i-ISO14001 kunye nezatifikethi ze-OHSAS18001.I-Veyong idweliswe kumashishini amashishini asakhasayo anobuchule kwiPhondo laseHebei kwaye inokuqinisekisa ukubonelela ngokuqhubekayo kweemveliso.
I-Veyong yaseka inkqubo epheleleyo yolawulo lomgangatho, yafumana isatifikethi se-ISO9001, isatifikethi se-GMP sase-China, isiqinisekiso se-APVMA se-GMP sase-Australia, isatifikethi se-GMP sase-Ethiopia, isatifikethi se-Ivermectin CEP, kwaye siphumelele ukuhlolwa kwe-US FDA.I-Veyong ineqela lobuchwephesha lobhaliso, intengiso kunye nenkonzo yobugcisa, inkampani yethu ifumene ukuthembela kunye nenkxaso kubathengi abaninzi ngomgangatho wemveliso ogqwesileyo, umgangatho ophezulu wokuthengisa kwangaphambili kunye nenkonzo yasemva kokuthengisa, ulawulo olunzulu kunye nolwenzululwazi.I-Veyong yenze intsebenziswano yexesha elide kunye namashishini amaninzi amachiza ezilwanyana awaziwayo ngamazwe ngamazwe kunye neemveliso ezithunyelwa eYurophu, eMzantsi Melika, kuMbindi Mpuma, e-Afrika, e-Asia, njl. ngaphezu kwamazwe angama-60 kunye nemimandla.
